Reimbursement Briefs: CMS Opens Transcatheter Mitral Valve NCA; OIG Looks At Medicare Hospital Outlier Payments
This article was originally published in The Gray Sheet
Executive Summary
CMS opens national coverage analysis for transcatheter mitral valve repair technology. OIG finds Medicare hospital outlier payments warrant a closer look. More reimbursement news.
You may also be interested in...
TAVR Gets Love, MitraClip Gets None In Medicare Inpatient Proposal
CMS proposes to grant new hospital inpatient payment categories for transcatheter valve replacements, a potential boon to Edwards’ and Medtronic’s devices. But the Medicare agency continues to stand firm against upgrading payment levels for Abbott’s MitraClip percutaneous mitral valve repair procedure.
CMS Policy Sets Boundaries On Transcatheter Valve Procedure
New Medicare coverage policy for transcatheter aortic valve replacement is a significant step for the nascent procedure and a possible window into how the agency will address future high-profile, early-stage technologies.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.